- How is kidney cancer treated?
- Surgery for kidney cancer
- Ablation and other local therapy for kidney cancer
- Active surveillance for kidney cancer
- Radiation therapy for kidney cancer
- Targeted therapies for kidney cancer
- Biologic therapy (immunotherapy) for kidney cancer
- Chemotherapy for kidney cancer
- Pain control for kidney cancer
- Clinical trials for kidney cancer
- Complementary and alternative therapies for kidney cancer
- Treatment choices by stage for kidney cancer
- More treatment information about kidney cancer
Biologic therapy (immunotherapy) for kidney cancer
The goal of biologic therapy is to boost the body’s immune system to help fight off or destroy cancer cells. The main immunotherapy drugs used in kidney cancer are cytokines (man-made versions of natural proteins that activate the immune system). The cytokines used most often are interleukin-2 (IL-2) and interferon-alpha. Both cytokines can cause kidney cancers to shrink in a small percentage of patients.
In the past, IL-2 was commonly used as first-line therapy for advanced kidney cancer, and it may still be helpful for some people. But because it can be hard to give and can cause serious side effects, many doctors only use it in patients who are healthy enough to withstand the side effects, or for cancers that aren’t responding to targeted drugs.
Although only a small percentage of patients respond to IL-2, it is the only therapy that appears to result in long-lasting responses. Doctors are now looking to see if certain patient and cancer characteristics can help predict if IL-2 will be helpful.
Giving high doses of IL-2 seems to offer the best chance of shrinking the cancer, but this can cause serious side effects, so it is not used in people who are in poor overall health to begin with. Special care is needed to recognize and treat these side effects. Because of this, high-dose IL-2 is only given in the hospital at certain centers that are experienced with giving this type of treatment.
The possible side effects of high-dose IL-2 include:
- Extreme fatigue
- Low blood pressure
- Fluid buildup in the lungs
- Trouble breathing
- Kidney damage
- Heart attacks
- Intestinal bleeding
- Diarrhea or abdominal pain
- High fever and chills
- Rapid heart beat
- Mental changes
These side effects are often severe and, rarely, can be fatal. Only doctors experienced in the use of these cytokines should give this treatment.
Interferon has less serious side effects than IL-2, but it does not seem to be as effective when used by itself. It is more often used in combination with the targeted drug bevacizumab (Avastin).
Common side effects of interferon include flu-like symptoms (fever, chills, muscle aches), fatigue, and nausea.
Newer approaches to immunotherapy
Cytokines can also be used as part of some experimental immunotherapy techniques. In one approach, immune system cells are removed from the blood and treated with cytokines in the lab to help activate them. These cells are then injected back into the patient in the hope that this will stimulate the immune system to fight the cancer.
In recent years, newer types of drugs that help boost the body’s immune response against cancer cells have shown early promise in kidney cancer. These and other newer forms of immunotherapy are described in the section “What’s new in kidney cancer research and treatment?”
Last Medical Review: 02/24/2014
Last Revised: 03/03/2015